Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Insmed's trading volume on March 2nd was $390 million, ranking 338th among U.S. stocks on that day.
On March 2, 2026, Insmed (INSM) had a trading volume of $390 million, ranking 338th among U.S. stocks that day. The trading volume decreased by 3.67% compared to yesterday, with a total of 2.6575 million shares traded.
Insmed (INSM) closed at $146.32 on March 2, 2026, down 2.02%. Over the past five trading days, the stock has fallen 7.99%. For March, it declined 2.02%, and year-to-date, it has decreased by 15.93%. Over the past 52 weeks, it has increased by 79.42%.
If the company has been listed for less than 52 weeks, the 52-week change is calculated from the listing date (this also applies if listed for less than 1 month or fewer than 5 trading days).
Insmed Incorporated was registered in Virginia on November 29, 1999, with its main administrative offices located in Bridgewater, New Jersey. Insmed is a people-centric biopharmaceutical company dedicated to providing innovative therapies to improve the lives of patients with serious diseases. Its commercial portfolio and clinical pipeline focus on three therapeutic areas: respiratory, immunology and inflammation, and neurology and other rare diseases.